ARTICLE | Company News
De Novo, GeneFormatics MMP deal
July 22, 2002 7:00 AM UTC
De Novo (Cambridge, U.K.) and GeneFormatics (San Diego, Calif.) partnered to identify small molecule inhibitors of the M10 family of matrix metalloproteinases (MMPs). GeneFormatics will use its proteo...